• Latest Posts

New biomarker for early prediction of response to CAR-T cell therapy

First CAR-T technology trial for patients with T-cell leukemia subtype authorized

In Depth 20 Dec 2022

Ebvallo approval ushers in off-the-shelf T-cell immunotherapies

Legend Biotech small cell lung cancer drug gets FDA ok for clinical development

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma


Spanish research institution to use Elicera Therapeutics’ iTANK platform

In Depth 11 Oct 2022

The biggest private biotech investments in September 2022

Mission Bio launches first commercial high-throughput cell therapy assay for measuring vector copy number

Bioheng Biotech has positive CAR-T cell therapy results published in academic journal

Interview 27 Sep 2022

Natural killer cells: a thriving frontier in allogeneic cell therapy

Startup Scout 22 Sep 2022

Cartography Biosciences unearths cancer immunotherapy targets